The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.

German drugmaker Merck KGaA said on Thursday ‌it would buy U.S. firm Bio-Techne for $11.3 billion, its biggest deal in more ...

Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life ...

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based ...

Merck provides 2026 and mid-term forecasts, confirms targets for 2025 Company is ready for more M&A with focus on life sciences, CEO says Shares fall after 2026 outlook announcement, after rising ...